GLP-1 Medication Cost Index, October 2026
Published medication prices, with the dose, fill definition and conditions that determine what the number means.
Sources reviewed . Dataset version 1.0.0.
Compare the price basis before comparing the price
A manufacturer's list price, a self-pay offer, an introductory offer and an insurance copayment are different measures. These tables show medication prices per stated package or fill, not the total cost of clinical care. Offers can change and eligibility applies.
This is brand-price research. Compounded preparation prices and Trimi treatment plans are outside the dataset.
| Medication / dose | Price per stated fill | Eligibility and conditions | Primary source |
|---|---|---|---|
| Wegovy, Single-dose pen0.25, 0.5, 1, 1.7, 2.4 mg | $1,349.02Manufacturer list price1 box of 4 single-dose pens, a 28-day supply | Manufacturer list price before discounts or rebates, not a patient copayment. Published per package. Actual pharmacy charges and insurance payments can differ. | Price sourceEligibility / termsReviewed |
| Wegovy, HD single-dose pen7.2 mg | $1,349.02Manufacturer list price1 box of 4 single-dose pens, a 28-day supply | Manufacturer list price before discounts or rebates, not a patient copayment. Published per package. Actual pharmacy charges and insurance payments can differ. | Price sourceEligibility / termsReviewed |
| Wegovy, Single-dose pen0.25, 0.5, 1, 1.7, 2.4 mg | $349Standard self-pay offer1 box of 4 single-dose pens, a 28-day supply | Eligible self-pay patients using the manufacturer's offer; prescription and program terms apply. Standard self-pay offer, separate from the limited first-two-fill offer. | Price sourceEligibility / termsReviewed |
| Wegovy, HD single-dose pen7.2 mg | $399Standard self-pay offer1 box of 4 single-dose pens, a 28-day supply | Eligible self-pay patients using the manufacturer's offer; prescription and program terms apply. Standard self-pay offer for the 7.2 mg presentation. | Price sourceEligibility / termsReviewed |
| Wegovy, Single-dose pen0.25, 0.5 mg | $199Limited introductory offer1 box of 4 single-dose pens, a 28-day supplyStandard price without this offer: $349 per stated fill. | Eligible retail Wegovy Savings Offer patients who have not redeemed a savings offer for Wegovy injection in the past 365 days; prescription and program terms apply. First 2 eligible 28-day fills only. The retail offer must be redeemed and the prescription filled by December 31, 2026. Third fill reverts to the standard pen offer. NovoCare Pharmacy has separate eligibility and deadlines and is not included in this row. | Price sourceEligibility / termsReviewed |
The introductory offer applies to the first two eligible fills of the starting doses. It is not an ongoing price for every dose. Manufacturer savings eligibility and restrictions apply; confirm current terms before filling a prescription.
| Medication / dose | Price per stated fill | Eligibility and conditions | Primary source |
|---|---|---|---|
| Zepbound, Single-dose vials or single-patient-use KwikPen2.5 mg | $299Standard self-pay offer4 single-dose vials or 1 single-patient-use KwikPen, a 28-day supply | Self-pay patients with a prescription; manufacturer's eligibility and program terms apply. 2.5 mg is a starting dose, not a maintenance dose. Injection supplies purchased separately; taxes or fees may apply. | Price sourceEligibility / termsReviewed |
| Zepbound, Single-dose vials or single-patient-use KwikPen5 mg | $399Standard self-pay offer4 single-dose vials or 1 single-patient-use KwikPen, a 28-day supply | Self-pay patients with a prescription; manufacturer's eligibility and program terms apply. Injection supplies purchased separately; taxes or fees may apply. | Price sourceEligibility / termsReviewed |
| Zepbound, Single-dose vials or single-patient-use KwikPen7.5 mg | $449Conditional Journey offer4 single-dose vials or 1 single-patient-use KwikPen, a 28-day supplyStandard price without this offer: $499 per stated fill. | Self-pay patients with a prescription; manufacturer's eligibility and program terms apply. Journey offer on the first eligible purchase; subsequent purchases within 45 days of prior delivery/receipt. Otherwise regular price applies. Injection supplies purchased separately; taxes or fees may apply. | Price sourceEligibility / termsReviewed |
| Zepbound, Single-dose vials or single-patient-use KwikPen10 mg | $449Conditional Journey offer4 single-dose vials or 1 single-patient-use KwikPen, a 28-day supplyStandard price without this offer: $699 per stated fill. | Self-pay patients with a prescription; manufacturer's eligibility and program terms apply. Journey offer on the first eligible purchase; subsequent purchases within 45 days of prior delivery/receipt. Otherwise regular price applies. Injection supplies purchased separately; taxes or fees may apply. | Price sourceEligibility / termsReviewed |
| Zepbound, Single-dose vials or single-patient-use KwikPen12.5 mg | $449Conditional Journey offer4 single-dose vials or 1 single-patient-use KwikPen, a 28-day supplyStandard price without this offer: $699 per stated fill. | Self-pay patients with a prescription; manufacturer's eligibility and program terms apply. Journey offer on the first eligible purchase; subsequent purchases within 45 days of prior delivery/receipt. Otherwise regular price applies. Injection supplies purchased separately; taxes or fees may apply. | Price sourceEligibility / termsReviewed |
| Zepbound, Single-dose vials or single-patient-use KwikPen15 mg | $449Conditional Journey offer4 single-dose vials or 1 single-patient-use KwikPen, a 28-day supplyStandard price without this offer: $699 per stated fill. | Self-pay patients with a prescription; manufacturer's eligibility and program terms apply. Journey offer on the first eligible purchase; subsequent purchases within 45 days of prior delivery/receipt. Otherwise regular price applies. Injection supplies purchased separately; taxes or fees may apply. | Price sourceEligibility / termsReviewed |
These rows describe single-dose vials and the single-patient-use KwikPen, not the single-dose pen. The Journey price applies to an eligible first purchase; continuing that offer requires a refill purchase within 45 days of the previous delivery or receipt. Supplies are separate and taxes or fees may apply.
| Medication / dose | Price per stated fill | Eligibility and conditions | Primary source |
|---|---|---|---|
| Wegovy, Injection | $50Medicare Bridge copayment1-month supply; Medicare defines this as 28 or 30 days depending on the drug | Certain Medicare Part D beneficiaries age 18+ who meet clinical criteria; prescription and prior authorization when requested. Not available to everyone with Medicare. Separate Medicare GLP-1 Bridge program, not a universal Part D copay. Zepbound single-dose pens and vials are excluded from the Bridge. Copayment does not count toward the Part D deductible or out-of-pocket limit. | Price sourceEligibility / termsReviewed |
| Zepbound, KwikPen only | $50Medicare Bridge copayment1-month supply; Medicare defines this as 28 or 30 days depending on the drug | Certain Medicare Part D beneficiaries age 18+ who meet clinical criteria; prescription and prior authorization when requested. Not available to everyone with Medicare. Separate Medicare GLP-1 Bridge program, not a universal Part D copay. Zepbound single-dose pens and vials are excluded from the Bridge. Copayment does not count toward the Part D deductible or out-of-pocket limit. | Price sourceEligibility / termsReviewed |
Medicare's temporary Bridge program has Part D enrollment, age and clinical requirements. A provider must prescribe a covered drug and complete prior authorization when requested. Regular Part D coverage and payments can differ. The table covers only these presentations; Medicare lists its full covered-drug scope and eligibility on the linked source page.
What this release does not price
A missing row means the source could not support a precise, comparable figure. It does not mean a drug costs nothing or is unavailable.
Ozempic list price
NovoCare displays two different list prices for the same listed presentations. No single numeric price is selected for this release.
NovoCare: Ozempic list-price page, unresolved displayed pricesMounjaro and Zepbound list prices
The current Lilly pricing-page reads did not expose a verifiable numeric list price. Earlier figures are not presented as newly verified prices.
Lilly: Mounjaro list-price page, numeric price not verifiedLilly: Zepbound list-price page, numeric price not verifiedTypical commercial insurance copay ranges
A savings-card minimum is not a typical patient payment or a supported upper bound. Plan-specific payments require an insurer or pharmacy quote.
NovoCare: Wegovy savings eligibility and termsAnnual forecasts and cost per pound lost
Twelve fills are not always a calendar year. Modeled trial-outcome comparisons and surgery/diet estimates are outside this medication-price export.
Methodology and sources
Trimi Health reads the manufacturer's or Medicare's published price together with the associated eligibility and offer terms. Each row records a named presentation, dose where specified, price basis, fill definition, primary source and review date.
The downloads preserve prices as integer US cents. A review date records when a source was checked, not when every price became effective. A blank field means no value was verified or the field does not apply; it never represents a zero price. In JSON, those fields are null and a dose-unspecified row has an empty dose list.
We do not infer a typical commercial-insurance payment from a savings-card minimum. We do not multiply a 28-day fill price by 12 and label it a calendar-year treatment cost. Introductory and refill-dependent prices retain their limitations. Pharmacy/service charges, supplies and clinical-care fees are not synthesized into an all-in quote.
The page and its CSV and JSON downloads use one reviewed dataset. The JSON includes field definitions and excluded-item explanations. These data describe published prices, not measured patient outcomes, prescribing advice or a prediction of an individual's costs.
- NovoCare: Wegovy prices and package definitions
- NovoCare: Wegovy savings eligibility and terms
- LillyDirect: Zepbound presentations and self-pay prices
- LillyDirect: Zepbound Self Pay Journey Program terms
- Medicare.gov: GLP-1 Bridge coverage, eligibility and copayment
- NovoCare: Ozempic list-price page, unresolved displayed prices
- Lilly: Mounjaro list-price page, numeric price not verified
- Lilly: Zepbound list-price page, numeric price not verified
Reuse, citation and corrections
This curated dataset is published under Creative Commons Attribution 4.0. Share or adapt it with attribution to Trimi Health and a link to this page. The license does not cover the linked publishers' documents.
Trimi Health. GLP-1 Medication Cost Index. Version 1.0.0, reviewed October 6, 2026. https://trytrimi.com/glp1-cost-index.
For a correction, send the row ID, exact primary-source URL and proposed change to research@trytrimi.com. Substantive changes receive a dataset version update.
Find more published studies on the Trimi research page.
For informational purposes only. Actual charges and coverage depend on the pharmacy, program, insurance and individual circumstances. Confirm current prices and eligibility with the named source and your provider before making treatment decisions. This dataset does not compare compounded preparations with FDA-approved brand drugs.
Trimi's compounded tirzepatide is $235 billed monthly or $125 a month on the annual plan ($1,500 upfront, 12-month commitment); the full tirzepatide plan table lists every plan, what is included and the renewal terms.
Trimi's compounded semaglutide is $175 billed monthly or $99 a month on the annual plan ($1,188 upfront, 12-month commitment); see the semaglutide plan table for every plan and its renewal terms.